Table 1 Basic characteristics of research objects.

From: The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictor of NAFLD prevalence and steatosis severity

Variables

Total (n = 6651)

Non-NAFLD (n = 3683)

NAFLD (n = 2968)

P

Age (years)

52 (36, 65)

48 (33, 64)

55 (41, 65)

 < 0.001

Age group

   

 < 0.001

 20–39 years

1999 (30.056)

1335 (36.248)

664 (22.372)

 

 40–59 years

2227 (33.484)

1113 (30.220)

1114 (37.534)

 

 60 + years

2425 (36.461)

1235 (33.532)

1190 (40.094)

 

Sex

   

 < 0.001

 Female

3453 (51.917)

2077 (56.394)

1376 (46.361)

 

 Male

3198 (48.083)

1606 (43.606)

1592 (53.639)

 

Race

   

 < 0.001

 Mexican American

841 (12.645)

341 (9.259)

500 (16.846)

 

 Non-Hispanic Black

1683 (25.304)

1070 (29.052)

613 (20.654)

 

 Non-Hispanic White

2262 (34.010)

1205 (32.718)

1057 (35.613)

 

 Other

1865 (28.041)

1067 (28.971)

798 (26.887)

 

Education

   

0.010

 College or above

3775 (56.758)

2140 (58.105)

1635 (55.088)

 

 High school or equivalent

1610 (24.207)

887 (24.084)

723 (24.360)

 

 Less than high school

1266 (19.035)

656 (17.812)

610 (20.553)

 

Smoking

   

0.036

  < 100 cigarettes in life

3996 (60.081)

2255 (61.227)

1741 (58.659)

 

  ≥ 100 cigarettes in life

2655 (39.919)

1428 (38.773)

1227 (41.341)

 

Marriage

   

 < 0.001

 Married/Living with partner

3875 (58.262)

2025 (54.982)

1850 (62.332)

 

 Never married

1281 (19.260)

820 (22.264)

461 (15.532)

 

 Widowed/Divorced/Separated

1495 (22.478)

838 (22.753)

657 (22.136)

 

Drinking

   

0.254

 No

671 (10.089)

386 (10.481)

285 (9.602)

 

 Yes

5980 (89.911)

3297 (89.519)

2683 (90.398)

 

 FMPIR

2.220 (1.200, 4.140)

2.220 (1.180, 4.170)

2.200 (1.220, 4.120)

0.772

 BMI

28.800 (25.000,33.8.000)

26.300 (23.200,30.000)

32.300 (28.400, 37.200)

 < 0.001

BMI group

   

 < 0.001

  < 25

1645 (24.733)

1432 (38.881)

213 (7.177)

 

  > 30

2870 (43.151)

942 (25.577)

1928 (64.960)

 

 25 ≤ BMI < 30

2136 (32.115)

1309 (35.542)

827 (27.864)

 

 SBP (mm/Hg)

121.670 (110.670, 134.000)

119.330 (109.000, 132.330)

124.330 (113.670, 135.750)

 < 0.001

 DBP (mm/Hg)

74.000 (66.670, 81.670)

72.330 (65.330,79.670)

76.000 (69.000, 83.670)

 < 0.001

 WC (cm)

99.600 (89.300, 111.500)

92.400 (83.300,102.200)

108.700 (99.000, 119.800)

 < 0.001

 TG (mmol/L)

1.290 (0.890, 1.850)

1.070 (0.780, 1.530)

1.570 (1.140, 2.180)

 < 0.001

 ALT (U/L)

17 (13, 24)

15 (12, 21)

20 (15, 28)

 < 0.001

 AST (U/L)

19 (16, 23)

18 (15, 22)

19 (16, 24)

 < 0.001

 HDLC (mmol/L)

1.290 (1.090, 1.550)

1.400 (1.190, 1.680)

1.160 (1.010, 1.400)

 < 0.001

 CAP (db/m)

265 (219, 310)

224 (198, 249)

316 (293, 347)

 < 0.001

 LSM (Kpa)

5.000 (4.100, 6.200)

4.600 (3.800, 5.600)

5.600 (4.500, 7.100)

 < 0.001

 TC (mmol/L)

4.730 (4.090, 5.430)

4.680 (4.030, 5.350)

4.780 (4.110, 5.510)

 < 0.001

 Non-HDLC (mmol/L)

3.340 (2.710, 4.060)

3.180 (2.590, 3.880)

3.570 (2.890, 4.240)

 < 0.001

 NHHR (mmol/L)

2.560 (1.870, 3.420)

2.240 (1.660, 2.990)

2.990 (2.230, 3.860)

 < 0.001

HTN

   

 < 0.001

 No

5569 (83.732)

3153 (85.610)

2416 (81.402)

 

 Yes

1082 (16.268)

530 (14.390)

552 (18.598)

 

HL

   

 < 0.001

 No

5911 (88.874)

3463 (94.027)

2448 (82.480)

 

 Yes

740 (11.126)

220 (5.973)

520 (17.520)

 

DM

   

 < 0.001

 No

5638 (84.769)

3350 (90.958)

2288 (77.089)

 

 Yes

1013 (15.231)

333 (9.042)

680 (22.911)

 
  1. NAFLD, Non-alcoholic fatty liver disease; FMPIR, family income and poverty-to-income ratio; BMI, Body Mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; TG, Triglycerides; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDLC, high-density lipoprotein cholesterol; CAP, controlled attenuation parameter; LSM, liver stiffness measurement; TC, total cholesterol; NHHR, non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol; HTN, hypertension; HL, hyperlipidemia; DM, diabetes mellitus.